Skip to main

Annual survey

We would appreciate it if you could complete our website survey, open until 28 November 2025.

Invitation to comment on a clinical trial of a genetically modified human adenovirus for treatment of melanoma (DIR 213)

Latest version
C2025G0015127 March 2025